Carvedilol Tablet, Film Coated
Product Images NDC 72888-037

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 72888-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-00)

Label for Carvedilol Tablets USP 12.5 mg, film-coated oral tablets. The package contains 1000 tablets. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, Ambernath, India. The label includes storage instructions, a warning about the seal, and references accompanying prescribing information.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-01)

Label for Carvedilol Tablets USP 12.5 mg by Advagen Pharma Ltd. Contains 100 film-coated tablets for oral use. The label includes storage instructions (store below 30°C, protect from moisture), a barcode, and distributor and manufacturer information. It also warns not to use if the seal under the cap is missing or broken.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-30)

Carvedilol Tablets, USP 12.5 mg film-coated tablets label showing 30 tablets per container. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label includes storage instructions, dosage note, and barcode. It specifies prescription use only and cautions about seal integrity.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-05)

Label for Carvedilol Tablets, USP 12.5 mg film-coated tablets, packaged in a bottle of 500 tablets. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label includes storage instructions to keep below 30°C and protect from moisture. Dosage information advises consulting prescribing information. Contains NDC 72888-036-05.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-00)

Label for Carvedilol Tablets, USP 25 mg by Advagen Pharma Ltd. The film-coated oral tablets come in a container of 1000 tablets. The label includes storage instructions, a barcode, and manufacturing details for Rubicon Research Private Limited, India. The NDC number 72888-037 is also displayed.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-01)

Carvedilol Tablets USP 25 mg film-coated tablets packaging label. The label states each tablet contains 25 mg carvedilol, with a quantity of 100 tablets per container. Distributed by Advagen Pharma Limited, Plainsboro, NJ, USA, and manufactured by Rubicon Research Private Limited, India. The label includes storage instructions and barcode information.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-30)

Label for Carvedilol Tablets USP 25 mg film-coated tablets. The label indicates a package size of 30 tablets, distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. Storage instructions specify protecting from moisture and storing below 30°C. The label includes a barcode and cautions not to accept if the seal is broken.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-05)

Label for Carvedilol Tablets, USP 25 mg film-coated tablets. Packaging states 500 tablets, Rx only, distributed by Advagen Pharma Limited, and manufactured by Rubicon Research Private Limited in India. Label includes storage instructions, dosage caution, and barcodes.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-00)

Label for Carvedilol Tablets USP 3.125 mg film-coated tablets, packaged in a container of 1000 tablets. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label includes storage instructions, a warning about the seal under the cap, and a barcode.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-01)

Carvedilol Tablets, USP 3.125 mg film-coated tablets label from Advagen Pharma Ltd. The label shows storage instructions, dosage advisory, NDC 72888-034-01, and packaging of 100 tablets. Manufactured by Rubicon Research Private Limited in India, distributed by Advagen Pharma Limited, Plainsboro, NJ, USA.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-30)

Carvedilol Tablets, USP 3.125 mg film-coated tablets, packaged in a container of 30 tablets. Label shows NDC 72888-034-30, distributed by Advagen Pharma Limited, and manufactured by Rubicon Research Private Limited. Storage instructions and a barcode are also visible.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-05)

Label for Carvedilol Tablets USP 3.125 mg film-coated tablets. The label states the strength as 3.125 mg, package count of 500 tablets, and notes that it is Rx only. It lists Advagen Pharma Limited as the distributor and Rubicon Research Private Limited as the manufacturer. The label includes storage instructions and barcode with NDC 72888-034-05.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-00)

Carvedilol Tablets, USP 6.25 mg film-coated tablet label with a count of 1000 tablets. The label includes the NDC 72888-035-00 and storage instructions below 30°C to protect from moisture. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. Label includes warnings about the seal under the cap and dosage information reference.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-01)

Label for Carvedilol Tablets USP 6.25 mg, film-coated tablets, packaged with 100 tablets. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Label includes storage instructions, barcode, and prescribing information note. This is a prescription drug for oral use.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-30)

Label for Carvedilol Tablets, USP 6.25 mg film-coated tablets. The package contains 30 tablets and is labeled for prescription use only. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label includes dosage form, strength, storage instructions, barcode, and warnings about the seal and container.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-05)

Carvedilol Tablets USP 6.25 mg film-coated tablets packaging label. The bottle contains 500 tablets and is for prescription use only. Distributed by Advagen Pharma Limited, Plainsboro, NJ, USA, and manufactured by Rubicon Research Private Limited, Thane, India. Storage instructions and caution about the seal integrity are also included.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line graph depicting mortality percentage over 21 months comparing Carvedilol to Placebo. The x-axis represents time in months, and the y-axis shows mortality percentage. The Carvedilol group shows consistently lower mortality than the Placebo group, with a p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot chart showing hazard ratios for various subgroups including men, women, age groups (<65 and ≥65), race (black and non-black), diabetic status, ischemic status, heart rate categories (>70 and <70), systolic blood pressure categories (≥120 mm Hg and <120 mm Hg), spironolactone use, and all patients. Each subgroup has a corresponding hazard ratio with confidence intervals plotted against a vertical reference line at 1.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line graph comparing percent mortality over 24 months between Carvedilol and placebo groups. The x-axis represents time in months, while the y-axis shows percent mortality. The Carvedilol group shows a consistently lower mortality rate than the placebo group, with a noted p-value of 0.03 indicating statistical significance.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A forest plot chart depicting hazard ratios with confidence intervals for various subgroups related to myocardial infarction and heart failure factors. The subgroups include age, gender, treatment timing, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA for MI, heart failure history, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The x-axis represents hazard ratios from 0.4 to 1.3 with a reference line at 1.0.*

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure of carvedilol, a pharmaceutical active ingredient, showing detailed molecular arrangement with aromatic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.